日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor-Positive/HER2-/PIK3CA Wild-Type Advanced Breast Cancer

VIKTORIA-1试验:Gedatolisib联合Fulvestrant,加或不加Palbociclib治疗激素受体阳性/HER2-/PIK3CA野生型晚期乳腺癌

Hurvitz, Sara A; Layman, Rachel M; Curigliano, Giuseppe; André, Fabrice; Cristofanilli, Massimo; Kim, Sung-Bae; Martínez Rodríguez, Jorge Luis; Nadal, Jorge C; Kim, Gun Min; Lo, Louisa; Remolina-Bonilla, Yuly A; Rosselli, Geronimo; Emile, George; Korbenfeld, Ernesto; Puig, Juan Manuel; Wesolowski, Robert; Martin, Miguel; Ring, Alistair; Han, Hyo S; Giordano, Antonio; Mutka, Sarah C; Moss, Keren; Suzuki, Sam; Sullivan, Brian; Gorbatchevsky, Igor; Pistilli, Barbara

Advancing clinical integration of circulating tumor cells: Outcomes of an international expert consensus

推进循环肿瘤细胞的临床应用:国际专家共识的成果

Cristofanilli, Massimo; Jose Serrano, M

MGAT1-Guided complex N-Glycans on CD73 regulate immune evasion in triple-negative breast cancer

MGAT1引导的CD73上的复杂N-糖链调控三阴性乳腺癌的免疫逃逸

Chi, Junlong Jack; Xie, Ping; Cheng, Mary Hongying; Zhu, Yueming; Cui, Xin; Watson, Joshua; Zeng, Lidan; Uddin, Amad; Nguyen, Hoang; Li, Lei; Moremen, Kelley; Reedy, April; Wyatt, Megan; Marcus, Adam; Dai, Mingji; Paulos, Chrystal M; Cristofanilli, Massimo; Gradishar, William J; Zhao, Shaying; Kalinsky, Kevin; Hung, Mine-Chie; Bahar, Ivet; Zhang, Bin; Wan, Yong

Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis

PREDICT全球汇总分析中重复循环肿瘤细胞计数作为转移性乳腺癌早期治疗监测工具的临床有效性

Janni, Wolfgang; Friedl, Thomas W P; Yab, Tracy C; Bidard, Francois-Clément; Cristofanilli, Massimo; Hayes, Daniel F; Ignatiadis, Michail; Regan, Meredith M; Alix-Panabieres, Catherine; Barlow, William E; Caldas, Carlos; Carey, Lisa A; Dirix, Luc; Fehm, Tanja; Garcia-Saenz, Jose A; Gazzaniga, Paola; Generali, Daniele; Gerratana, Lorenzo; Gisbert-Criado, Rafael; Jacot, William; Jiang, Zefei; Joosse, Simon A; Lianidou, Evi; López López, Rafael; Magbanua, Mark J M; Manso, Luis; Mavroudis, Dimitris; Müller, Volkmar; Munzone, Elisabetta; Pantel, Klaus; Pierga, Jean-Yves; Rack, Brigitte; Riethdorf, Sabine; Rugo, Hope S; Sideras, Kostandinos; Sleijfer, Stefan; Smerage, Jeffrey; Stebbing, Justin; Terstappen, Leon W M M; Vidal-Martínez, Jose; Wallwiener, Markus; Giridhar, Karthik V; Liu, Minetta C

Racial Differences in ctDNA Profiles, Targeted Therapy Use, and Outcomes in Metastatic Breast Cancer

转移性乳腺癌中ctDNA谱、靶向治疗使用和预后的种族差异

Podany, Emily L; Foffano, Lorenzo; Gerratana, Lorenzo; Medford, Arielle J; Clifton, Katherine; Tapiavala, Shaili; Velimirovic, Marko; Lipsyc-Sharf, Marla; Reduzzi, Carolina; Bubie, Adrian; Putur, Annika; Ademuyiwa, Foluso O; Puglisi, Fabio; Gradishar, William J; Ma, Cynthia X; Bardia, Aditya; Cristofanilli, Massimo; Davis, Andrew A

Mapping breast cancer therapy with circulating tumor cells: The expert perspective

利用循环肿瘤细胞绘制乳腺癌治疗图谱:专家视角

Gerratana, Lorenzo; Gianni, Caterina; Nicolò, Eleonora; Pontolillo, Letizia; Bidard, Francois-Clement; Reduzzi, Carolina; Cristofanilli, Massimo

Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2- metastatic breast cancer: a retrospective multi-institutional Consortium analysis

HR+/HER2-转移性乳腺癌患者接受细胞周期蛋白依赖性激酶4/6抑制剂治疗后循环基因组图谱的变化:一项回顾性多中心联盟分析

Pontolillo, Letizia; Davis, Andrew A; Gerratana, Lorenzo; Medford, Arielle J; Wang, Judy; Nicolo', Eleonora; Clifton, Katherine; Velimirovic, Marko; Warrior, Surbhi; Podany, Emily; Andreopoulou, Eleni; Serafini, Mara Serena; Munoz-Arcos, Laura; Molteni, Elisabetta; Lipsyc-Sharf, Marla; Gianni, Caterina; Bayou, Nadia; Dai, Charles S; Giannarelli, Diana; Bria, Emilio; Ma, Cynthia X; Bardia, Aditya; Reduzzi, Carolina; Cristofanilli, Massimo

Quantitative HER2 profiling on circulating tumor cells using an EpCAM-independent platform in metastatic breast cancer.

利用不依赖于EpCAM的平台对转移性乳腺癌的循环肿瘤细胞进行HER2定量分析。

Bayou Nadia, Henretta Sarah, Munoz-Arcos Laura, Molteni Elisabetta, Gianni Caterina, Serafini Mara Serena, Nicolò Eleonora, Pontolillo Letizia, Pasto Brenno, Gaudio Hunter Andrew, Manai Maroua, Afghan Muhammad Maaz Khan, Manohar Jyothi, Elemento Olivier, Andreopoulou Eleni, Cristofanilli Massimo, Reduzzi Carolina

TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer

TROPION-Breast05:一项随机III期研究,比较Dato-DXd联合或不联合度伐利尤单抗与化疗联合帕博利珠单抗治疗PD-L1高表达的局部复发性不可切除或转移性三阴性乳腺癌患者的疗效。

Schmid, Peter; Oliveira, Mafalda; O'Shaughnessy, Joyce; Cristofanilli, Massimo; Graff, Stephanie L; Im, Seock-Ah; Loi, Sherene; Saji, Shigehira; Wang, Shusen; Cescon, David W; Hovey, Tina; Nawrot, Agata; Tse, Karson; Vukovic, Petra; Curigliano, Giuseppe

Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis

帕博西尼联合内分泌治疗治疗HR阳性/HER2阴性转移性乳腺癌的真实世界研究与随机研究的疗效比较:系统评价和荟萃分析

Schettini, Francesco; Nucera, Sabrina; Di Grazia, Giuseppe; Giudici, Fabiola; Strina, Carla; Milani, Manuela; Tancredi, Richard; Conte, Benedetta; Criscitiello, Carmen; Giuliano, Mario; Lambertini, Matteo; Sánchez-Bayona, Rodrigo; Pascual, Tomás; Arpino, Grazia; Del Mastro, Lucia; Vigneri, Paolo; Cristofanilli, Massimo; Rugo, Hope S; Gennari, Alessandra; Curigliano, Giuseppe; Generali, Daniele